HGF/c-Met raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-16 and is reviewed periodically as new material appears.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
| Property | Value | Notes |
|---|---|---|
| Primary proposed target | HGF/c-Met signaling | Direct binding not confirmed |
| Research models | Rodent and cell studies | Preclinical only |
| Human clinical data | None published | Safety and efficacy unknown |
| Regulatory status | Unapproved research chemical | Status varies by country |
| Typical research purity | 95% or higher by HPLC | Depends on supplier and batch |
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
While initially credited for China's suppression of the COVID-19 outbreak, the policy was later criticized by foreign and some domestic observers for being out of touch with the rest of the world and taking a heavy toll on the economy. This approach has especially come under criticism during a 2022 lockdown on Shanghai, which forced millions to their homes and damaged the city's economy. Conversely, Xi has said that the policy was designed to protect people's life safety. On 23 July 2022, the National Health Commission reported that Xi and other top leaders have taken the local COVID-19 vaccines. At the 20th CCP Congress, Xi confirmed the continuation of the zero-COVID policy, stating he would "unswervingly" carry out "dynamic zero-COVID" and promising to "resolutely win the battle", though China started a limited easing of the policies in the following weeks. In November 2022, protests broke out against China's COVID-19 policies, with a fire in a high-rise apartment building in Ürümqi being the trigger. The protests were held in multiple major cities, with some of the protesters demanding the end of Xi's and the CCP's rule. The protests were mostly suppressed by December. Follwing the protests, the government further eased COVID-19 restrictions. On 7 December 2022, China announced large-scale changes to its COVID-19 policy, including allowing quarantine at home for mild infections, reducing of PCR testing, and decreasing the power of local officials to implement lockdowns, effectively ending the zero-COVID policy.
Clinical Allergology Clinical Chemistry Clinical Haematology Clinical Immunology and Blood Banking Clinical Microbiology Clinical Pharmacology Molecular Biology and Genetics Reproduction and Fertility Thrombosis and Haemostasis Toxicology The NPU terminology is supported by a joint committee (C-SC-NPU) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and a subcommittee of the International Union of Pure and Applied Chemistry (IUPAC). The terminology is freely available for download in its generic version (in English [3]) and various language versions. The specific syntax and the references to international terminologies, classifications and nomenclatures make the terminology definitions language-independent.
== History == Norketamine was synthesized by Calvin Lee Stevens in the early 1960s, as part of his team's work on α-aminoketones at Wayne State University. While most research has historically focused on its precursor, researchers have taken notice of norketamine's putative effects. Beginning in the late 1990s, Danish researchers discovered its role as a NMDA receptor antagonist. Later research uncovered its use as an antinociceptive, or "painkiller." Following the 2019 approval of the ketamine enantiomer esketamine by the European Medicines Agency and FDA for use with treatment-resistant depression, researchers and pharmaceutical companies have sought other effective intermediates and metabolites of racemic ketamine. Much of the research examining the potential role of norketamine as a distinct anti-depressant to its precursor began in the mid-2010s. Rodent models have showcased that norketamine crosses the blood-brain barrier, though considerably less efficiently than ketamine. Accordingly, its antidepressant effects are less potent than enantiomers of ketamine, but appear to be as effective as esketamine in its potency and duration. Unlike esketamine, (S)-norketamine does not appear to significantly impact prepulse inhibition (reduction of the startle reflex) and as such appears to have significantly fewer psychotomimetic effects - which may indicate that it could be a safer alternative to ketamine for use as an antidepressant in humans.
=== Pharmacokinetics === Sirolimus is metabolized primarily by the CYP3A4 enzyme (about 90%), and to a lesser degree by CYP3A5 and CYP2C8. It is also a substrate of the P-glycoprotein (P-gp) efflux pump. It has linear pharmacokinetics. In studies on N=6 and N=36 subjects, peak concentration was obtained in 1.3 hours +/r- 0.5 hours and the terminal elimination was slow, with a half life around 60 hours +/- 10 hours. Sirolimus was not found to effect the concentration of ciclosporin, which is also metabolized primarily by the CYP3A4 enzyme. The bioavailabiliy of sirolimus is low, and the absorption of sirolimus into the blood stream from the intestine varies widely between patients, with some patients having up to eight times more exposure than others for the same dose. Drug levels are, therefore, taken to make sure patients get the right dose for their condition. This is determined by taking a blood sample before the next dose, which gives the trough level. However, good correlation is noted between trough concentration levels and drug exposure, known as area under the concentration-time curve, for both sirolimus (SRL) and tacrolimus (TAC) (SRL: r2 = 0.83; TAC: r2 = 0.82), so only one level need be taken to know its pharmacokinetic (PK) profile. PK profiles of SRL and of TAC are unaltered by simultaneous administration. Dose-corrected drug exposure of TAC correlates with SRL (r2 = 0.8), so patients have similar bioavailability of both.
Flower preservation has existed since early history, although deliberate flower preservation is a more recent phenomenon. In the Middle East, the bones of pre-historic man were discovered with delicate wild flowers probably as a tribute to a passing loved one. Evidence of deliberate use of specific flowers is indicated by the pollen grains that were present. Brightly colored and vivid flowers were also found in Egyptian tombs. These flowers were approximated to be 4,000 years old. In the sixteenth century medicinal nosegays began to give way to ornamental ones. Flowers essentially started to be used for decorative purposes such as jewels, fans and gloves. During the Elizabethan Age the once familiar ruff was replaced by soft lacy collars, and bosom flowers also became popular.
Sources: en.wikipedia.org
After the first two days the insurgents lost their offensive initiative, and the combined South African forces drove PLAN back across the border in a counteroffensive codenamed Operation Merlyn. Between 1 and 9 April 1989, 273 PLAN insurgents were killed in the fighting. The SADF and police suffered 23 dead. On 8 April 1989, the JMMC issued the Mount Etjo Declaration, which reiterated that the Tripartite Accord was still in effect and that South Africa, Angola, and Cuba remained committed to peace. It also ordered all PLAN insurgents remaining in Ovamboland to surrender at UNTAG-supervised assembly points. Sam Nujoma denied any incursion had taken place on 1 April, claiming that he had only ordered PLAN insurgents already inside South West Africa to begin establishing base camps. He also pointed out that SWAPO had never been a signatory to the Tripartite Accord, and therefore the cessation of hostilities as dictated by its terms was non-binding. This drew some ire from Angola, which had given guarantees to the UN that PLAN would remain north of the 16th parallel. The SADF was re-confined to its bases on 26 April, then released into Ovamboland again to verify that the insurgents had departed. By May, all but a small handful of PLAN insurgents had been relocated north of the 16th parallel under JMMC supervision, effectively ending the South African Border War. General elections under a universal franchise were held in South West Africa between 7 and 11 November 1989, returning 57% of the popular vote for SWAPO.
== Further reading == Kube, Massimo; Kohler, Fabian; Feigl, Elija; Nagel-Yüksel, Baki; Willner, Elena M.; Funke, Jonas J.; Gerling, Thomas; Stömmer, Pierre; Honemann, Maximilian N.; Martin, Thomas G.; Scheres, Sjors H. W.; Dietz, Hendrik (December 2020). "Revealing the structures of megadalton-scale DNA complexes with nucleotide resolution". Nature Communications. 11 (1): 6229. Bibcode:2020NatCo..11.6229K. doi:10.1038/s41467-020-20020-7. PMC 7718922. PMID 33277481.
== Career == Chen began her career at the Institute of Chemistry of Academia Sinica as assistant research fellow in 1999. She was the Director of the Institute of Chemistry from 2013 to 2019, and is currently a Distinguished Research Fellow. She is also an adjunct professor at National Taiwan University, National Chiayi University, National Taiwan Ocean University, and National Chung Hsing University. She conducts research in mass spectrometry-based bioinformatics, in relation to understanding diseases such as cancer. Since 2016, Chen has participated in the US Cancer Moonshot Initiative, providing proteogenomics expertise as representative of Academia Sinica. She is the project investigator for the Taiwan Cancer Moonshot Project, which analyzes multiomic data related to gastric cancer. She participates in the Chromosome-centric Human Proteome Project, and is the group lead of chromosome 4. Chen served as president for the Human Proteome Organization (2021-2022), the Taiwan Proteomics Society, and the Taiwan Society for Mass Spectrometry (2012-2015). She has been a council member of the Asia Oceania Human Proteome Organization since 2019. She current serves as executive director of the Taiwan Proteomics Society (2021-2023), and the Taiwan Society for Mass Spectrometry. She served on editorial boards of European Journal of Mass Spectrometry, Journal of Proteome Research, and Frontiers in Analytical Chemistry, and currently serves on the Executive Advisory Board of Proteomics.
Erik Johnson, the project lead, said that the Hunters are "big and impressive, but they can go anywhere the player can go", as the player can encounter them both indoors and outdoors. Ted Backman, a senior artist, said the Hunter can express emotions to show the player it is aggressive, hurt, or angry. Hunters are aggressive and they tend to operate in packs, but can also be found supporting other Combine troops. Later, they support Strider enemies, using their flechette guns to protect them. Hunters primarily attack the player by bracing themselves and firing bursts from their flechette cannon. Four flechettes can vaporize an ordinary human soldier. If they do not strike a living target, the flechettes charge up for several seconds and then explode, dealing minor damage to everything nearby. Hunters may also conduct a charging attack or strike with their legs if the player gets too close. Hunters are vulnerable to all weapons, but to compensate, are still quite resilient, making explosives and the pulse rifle's charged energy ball the most attractive options. Objects thrown with the gravity gun are also effective, especially if the player catches some of their flechettes with the object before hurling it. In outdoor environments, they can be run over with a vehicle.
=== Hydrogen isotope formation === 1H, with one proton and no neutrons, is the most abundant nuclide in the Solar System, formed in the earliest rounds of stellar explosions after the Big Bang. After the universe exploded into life, the hot and dense cloud of particles began to cool, first forming subatomic particles like quarks and electrons, which then condensed to form protons and neutrons. Elements larger than hydrogen and helium were produced with successive stars, forming from the energy released during supernovae. Deuterium, 2H, with one proton and one neutron, is also known to have cosmic origin. Like protium, deuterium was produced very early in the universe's history, during Big Bang nucleosynthesis (BBN). As protons and neutrons combined, helium-4 was produced with a deuterium intermediate. Alpha reactions with 4He produce many of the larger elements that dominate today's Solar System. However, before the universe cooled, high-energy photons destroyed any deuterium, preventing larger element formation. This is called the deuterium bottleneck, a restriction on the timeline for nucleosynthesis. All of today's deuterium originated from this proton-proton fusion after enough cooling. Tritium, 3H, with one proton and two neutrons, was produced by proton and neutron collisions in the early universe as well, but it has since radioactively decayed to helium-3. Today's tritium cannot be from BBN, due to tritium's short half-life, 12.3 years. Today's 3H concentration is instead governed by nuclear reactions and cosmic rays.
Sources: en.wikipedia.org
=== Cancer === As of 2023, regulatory agencies, including the FDA and EFSA, and the US National Cancer Institute, have concluded that consuming aspartame is safe in amounts within acceptable daily intake levels and does not cause cancer. These conclusions are based on various sources of evidence, such as reviews and epidemiological studies finding no association between aspartame and cancer. In July 2023, scientists for the International Agency for Research on Cancer (IARC) concluded that there was "limited evidence" for aspartame causing cancer in humans, classifying the sweetener as Group 2B (possibly carcinogenic). The lead investigator of the IARC report stated that the classification "shouldn't really be taken as a direct statement that indicates that there is a known cancer hazard from consuming aspartame. This is really more of a call to the research community to try to better clarify and understand the carcinogenic hazard that may or may not be posed by aspartame consumption." The Joint FAO/WHO Expert Committee on Food Additives (JECFA) added that the limited cancer assessment indicated no reason to change the recommended acceptable daily intake level of 40 mg per kg of body weight per day, reaffirming the safety of consuming aspartame within this limit.
. The Burnett equations include additional second-order derivatives of velocity, temperature, and density, representing more subtle effects of non-equilibrium gas dynamics. The Burnett equations can be expressed as:
==== ACTH and GH release ==== TRH promotes release growth hormone (GH) in individuals with certain pathological conditions, and of adrenocorticotropic hormone (ACTH) in some individuals with Cushing's disease. TRH promotes GH release in individuals with acromegaly; prolonged exposure to GHRH may cause the pituitary to release GH in response to TRH. TRH may also promote GH release in individuals with hepatic disease, uremia, childhood hypothyroidism, anorexia nervosa, and depression. Conversely, TRH suppresses GH release during sleep.
=== UN treaties and US influence === The three UN drug control conventions, adopted by over 180 countries, provide a legal framework for cooperation between countries. Each state is obligated to incorporate the treaty provisions in their domestic laws. While there is a degree of interpretative flexibility, "each of the treaties encourages – and often requires – that member countries put in place strong domestic penal provisions" to deal with illicit drugs; punitive policies have been the common approach. The US, emerging as the dominant power after WWII, exerted considerable influence over how the conventions were adopted by other nations, promoting a prohibitionist and criminalizing view. Historically, the US has been "the key player in most multilateral negotiations" and the prohibitionist approach "derives largely from U.S. policy – the various forms, past and present, of the U.S. 'war on drugs'". US economic power is focused on the war on drugs through the Foreign Assistance Act (FAA). Enacted in 1961, the FAA integrated various federal foreign aid initiatives under the new US Agency for International Development (USAID), and has remained the core legislation governing foreign financial assistance. In 1972, reacting to concerns over illicit drugs from foreign sources, Congress added an "International Narcotics Control" chapter to the FAA, which allowed the president to enter into agreements and provide assistance for counternarcotic activities in foreign countries.
== Identification == Fossil dinosaur eggshell fragments can be recognized based on three important traits. Their thickness should be roughly uniform, they are usually slightly curved, and their surface is covered in tiny pores. Less frequently, the concave underside of the eggshell fragment will preserve bumps known as mammillae. Sometimes the embryo had absorbed so much of the calcium that the mammillae need a magnifying glass or microscope to be seen. However, there are many kinds of naturally occurring objects which can resemble fossil eggs. These can fool even professional paleontologists.
Sources: en.wikipedia.org
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.
No published human clinical trials are available for dihexa. Its safety and effectiveness in people are therefore unknown. Most available evidence comes from animal and cell studies.
Preclinical studies often measure dendritic spine density and synaptic protein levels. Behavioral tests include maze learning and avoidance tasks. These endpoints are indirect and do not establish clinical benefit.
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.